Delivery Order SPE2DE21D7020-SPE2D623F2DUB

Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $7,688.80 by the Defense Health Agency's Medical Supply Chain division on September 29, 2023, with an ultimate completion date of October 6, 2023. This fixed-price delivery order with economic price adjustment was issued against an established Blanket Purchase Agreement (BPA) and carries no small business set-aside designation. The contract represents Boston Scientific's continued role as a critical supplier of specialized medical devices and radiation treatment technologies to federal healthcare entities, including the Department of Veterans Affairs and military healthcare facilities.

The delivery order supports the Defense Health Agency's procurement of radiation oncology equipment and related medical devices, consistent with Boston Scientific's extensive portfolio of federal contracts encompassing cardiac devices, neuromodulation systems, ablation technologies, and radiation treatment modalities. As the parent corporation serving the federal government through established indefinite delivery vehicles and direct awards, Boston Scientific fulfills rapid resupply requirements across the defense and veterans healthcare enterprises. The BPA structure, valued at $750,000 with a completion date of March 30, 2030, positions Boston Scientific as the sole supplier for radiation treatment devices to the Defense Health Agency, demonstrating the government's confidence in the company's capability to maintain supply chain continuity for critical cancer treatment technologies.